OrthoPediatrics Corp. reported a strong Q2 2025 with 16% revenue growth, beating expectations, and raised its 2025 revenue outlook, driven by strategic expansion and market share gains.

OrthoPediatrics Corp is preparing to release its Q1 earnings on May 7, 2025, amidst fluctuations in its stock price and complex financial metrics.

OrthoPediatrics Corp is preparing to release its Q1 earnings on May 7, 2025, which will provide insight into the company’s financial health and future prospects.

OrthoPediatrics Corp. has shown resilience and potential for growth, with a recent surge in stock price amidst market challenges, driven by its commitment to developing innovative orthopedic solutions for child safety and injury prevention.